Quinoxaline derivatives useful as FGFR kinase modulators
US9902714B2 · kind B2 · utility
15Cited by
27References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 2015 |
| Grant date | Feb 27, 2018 |
| Priority date | — |
| Expiry date | Mar 26, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to new quinoxaline derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.